Purine and Pyrimidine Metabolism Flashcards
Nucleoside
base + pentose sugar
Nucleotide
Base + phosphorylated pentose sugar
Source of purines and pyrimidines in the body
de novo synthesis from other component molecules, or through recycling of pre-existing bases and combining with sugar moieties
diet –> minimal contribution
Activators and inhibitors of PRPP synthetase
Activator: Pi
Inhibitors: purine ribonucleotides
Key regulated steps in purine de novo synthesis
PRPP + glutamine (glutamine phosphoribosyl pyrophosphate amidotransferase) –> 5-phosphoribosylamine (adds first N to PRPP)
conversion of ribose 5’-phosphate to PRPP via PRPP synthetase
First base produced by de novo synthesis of purines
inosine mono-phosphate (IMP), which is used to make GMP and AMP by enzymes
failure of enzymes –> autism
Regulation of purine synthesis
Activators: PRPP
Inhibitors: AMP, GMP, IMP
Order of pyrimidine synthesis
pyrimidine base ring is made and then added to the sugar
Key regulated step in pyrimidine synthesis
2 ATP + CO2 + glutamine (carbamoyl phosphate synthetase II) –> carbamoyl phosphate + glutamate
occurs in the cytosol
Regulation of key step in pyrimidine synthesis
activator: PRPP, ATP
Inhibitor: UTP
first nucleotide produced by pyrimidine synthesis
uracil mono-phosphate (UMP)
Process of making cytosine (CTP)
UMP –> UDP –> UTP (CTP synthase, glutamine) –> CTP + glutamate
Enzymes catalyzing changes in phosphoyrlation states of nucleotides
Base-specific nucleoside monophosphate kinases: adenylate kinase, guanylate kinase
Nucleoside diphosphate kinase
Enzyme converting nucleotides to deoxynucleotides
ribonucleotide reductase (operates on diphosphates)
regulation of ribonucleotide reductase
sensing of concentration of dNTPs.
primary regulation site is active in the presence of ATP, inactive when dATP builds up
substrate specific site is sensitive to specific dNTP concentrations. able to switch between operating on one NDP to another